Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Using a teletriage system greatly increased access to skin care for uninsured Latino immigrants at a clinic.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Trichoscopy helps accurately diagnose temporal triangular alopecia.

5-ARI therapy may help prevent prostate cancer progression.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Recognizing congenital triangular alopecia is crucial to avoid unnecessary treatments.

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

Improved CRBN ligands make protein degraders more effective and drug-like.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

A new mutation in the TRPS1 gene was found in a Ukrainian girl with Trichorhinophalangeal syndrome type I.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

GIANT improves brain imaging by using genetics to better map brain regions.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

High-dose thiotepa and twice-daily treatments increase the risk of permanent hair loss in children receiving craniospinal irradiation.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

A rare biotin deficiency in an Iraqi family caused severe symptoms but was successfully treated with lifelong biotin.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Newborn screening for biotinidase deficiency is effective in preventing severe complications.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

Burn reconstruction is crucial for improving long-term outcomes for burn survivors.

An 11-year-old girl with severe hair loss regrew and repigmented her hair after JAK inhibitor treatment.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.